Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV plus NPC) Meeting Abstract
| Authors: | Siu, L. L.; Bauml, J.; Adkins, D.; Colevas, A. D.; Perez, C. A.; Choe, J. H.; Zhang, Y.; Shi, W.; Navarro, W. H.; Haigentz, M.; Rabinowits, G.; Pfister, D. G. |
| Abstract Title: | Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV plus NPC) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 364s |
| Language: | English |
| ACCESSION: | WOS:000487345803410 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS6092 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS6092 -- Source: Wos |
